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Alzheimer’s disease (AD), which now seems to be one of the most common types of 
dementia, is alarming health, economic and social threat worldlwide. Despite of 
significant progression in research during the last decade, casual treatment remains 
still unknown. Treatment of AD is limited only to suppression of the symptoms by 
centrally acting inhibitors of acetylcholinesterase and memantine. Enzyme 
prolyloligopeptidase (POP) plays a role in regulation of neuronal peptides levels and 
therefore POP has gained attention as one of possible target for the treatment of 
neuronal disorders. Because effect of POP inhibitors on cognitive functions 
improvement was reported, the aim of this thesis was to determinate the inhibitory 
aktivity of newly prepared substabces. These substances were primarily designed as 
acetylcholinesterase inhibitors with potential N-methyl-D-aspartate (NMDA) receptor 
antagonism. Additional POP inhibitory potential of novel compounds would even better 
fit into a concept of multi-target directed ligands (MDTL). Spectrophotometric method 
with Z-Gly-Pro-p-nitroanilide as the substrate was used to test the inhibitory potential. 
However, the results showed that the substances had a very low affinity for POP. 
Based on these in vitro data their furhter use as developmental inhibitors can not be 
expected. 
 
